Latest stories on EWTX
8-K/A - Edgewise Therapeutics, Inc. (EWTX) files 8-K
SEC 8-K50 · neutralgeneral
Edgewise Therapeutics Sells Muscular Dystrophy Assets to Servier
TipRanks58 · neutralm&a
Edgewise Therapeutics, Inc. (EWTX) files 8-K
SEC 8-K50 · neutralgeneral
Servier finalise l'acquisition de l'activité dystrophie musculaire d'Edgewise Therapeutics
PR Newswire62 · neutralm&a
Servier completes the acquisition of Edgewise Therapeutics' Muscular Dystrophy Business
PR Newswire63 · neutralm&a
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
PR Newswire50 · neutralgeneral
Is Edgewise Therapeutics, Inc. (EWTX) A Good Stock To Buy Now?
Yahoo Top57 · neutralanalyst
Edgewise Therapeutics, Inc. (EWTX) Price Target Raised to $59 on Positive HCM Trial Data
Yahoo Top67 · bullishanalyst
Edgewise Therapeutics, Inc. (EWTX) Discusses Top Line Data From EDG-7500 Phase II CIRRUS-HCM Trial in Hypertrophic Cardiomyopathy Transcript
Seeking Alpha56 · neutralproduct/pr
Edgewise Bounds Between Double-Digit Losses And Gain — What's Going On?
Investors.com47 · neutralgeneral
Edgewise falls after trial data for heart disease therapy
Seeking Alpha34 · bearishproduct/pr
EDG-7500 Shows Consistent Efficacy and Safety Across Obstructive and Nonobstructive HCM in Phase 2 CIRRUS-HCM Data
MarketChameleon73 · bullishproduct/pr
Edgewise Therapeutics, Inc. (EWTX) files 8-K
SEC 8-K50 · neutralgeneral
Edgewise: 'Buy' On Muscular Dystrophy Program Sale And EDG-7500 Advancement
Seeking Alpha67 · bullishproduct/pr
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules | EWTX Stock News
StockTitan50 · neutralgeneral
How Edgewise Sweetened Its Coffers By $1.55 Billion, And Removed A Key Overhang
Yahoo Finance73 · bullishgeneral
Edgewise Therapeutics Sells Sevasemten, Refocuses on Cardiology
TipRanks42 · neutralgeneral
Servier projette d'acquérir l'activité dystrophie musculaire d'Edgewise Therapeutics
PR Newswire63 · neutralm&a
Servier to Acquire Edgewise Therapeutics' Muscular Dystrophy Business
PR Newswire63 · neutralm&a
Servier buys into muscular dystrophy with potentially $2.7B deal
Yahoo Top67 · bullishm&a